Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9F30

Human carbonic anhydrase XII with 3-(Cyclooctylamino)-5-ethoxy-2,6-difluoro-4-((3-hydroxypropyl)sulfonyl)benzenesulfonamide

This is a non-PDB format compatible entry.
Summary for 9F30
Entry DOI10.2210/pdb9f30/pdb
Related9F2N 9F2O
DescriptorCarbonic anhydrase 12, ZINC ION, DIMETHYL SULFOXIDE, ... (6 entities in total)
Functional Keywordsdrug design, carbonic anhydrase, benzenesulfonamide, lyase
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight123717.39
Authors
Manakova, E.,Grazulis, S.,Smirnov, A.,Paketuryte, V. (deposition date: 2024-04-24, release date: 2025-05-14, Last modification date: 2025-09-24)
Primary citationVaskevicius, A.,Zvirblis, M.,Kurtenoka, M.,Leitans, J.,Manakova, E.,Paketuryte-Latve, V.,Kvietkauskaite, A.,Kazaks, A.,Eimonta, V.,Cerepenkaite, K.,Kazokaite-Adomaitiene, J.,Mickeviciu̅te, A.,Juozapaitiene, V.,Tars, K.,Grazulis, S.,Matuliene, J.,Dudutiene, V.,Shubin, K.,Matulis, D.,Zubriene, A.
Di- meta -Substituted Fluorinated Benzenesulfonamides as Potent and Selective Anticancer Inhibitors of Carbonic Anhydrase IX and XII.
J.Med.Chem., 68:18389-18406, 2025
Cited by
PubMed Abstract: The development of selective drug candidate molecules for cancer-related carbonic anhydrase isozymes IX and XII is challenging due to high homology binding sites among 12 catalytically active isozymes. Starting from the trifluorinated benzenesulfonamide with cyclooctylamino substituent at the position, we designed and synthesized di--substituted fluorinated benzenesulfonamides with up to 10-fold affinity improvement for CAIX, resulting in low picomolar binders. The resulting CAIX-targeting compounds showed up to 1000-fold selectivity over off-target CA isozymes. The crystal structures of CAIX and CAXII complexes with synthesized compounds revealed detailed insights into protein-ligand interactions and adopted complex conformation. The potential of compounds with reduced off-target effects as possible anticancer drugs is supported by this study.
PubMed: 40833423
DOI: 10.1021/acs.jmedchem.5c01142
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.12 Å)
Structure validation

242500

数据于2025-10-01公开中

PDB statisticsPDBj update infoContact PDBjnumon